ArticleDrug design, development and therapy2026

Real-World Outcomes and Safety of PD-1 Blockade Rechallenge Strategies After Prior Immunotherapy in Advanced NSCLC: A Retrospective Cohort Study.

Ling-Jie Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.